Susan Vadaparampil, Ph.D., M.P.H.
H. Lee Moffitt Cancer Center & Research Institute
Dr. Susan Vadaparampil received a her bachelor's and master's degrees in Health Science Education from the University of Florida, an M.P.H. from Johns Hopkins University with an emphasis in Epidemiology, and a Ph.D. in Health Behavior from Indiana University in 2000.
then completed a postdoctoral fellowship in Cancer Prevention at the National Cancer Institute
Dr. Vadaparampil is currently an Assistant Professor in the Department of Interdisciplinary Oncology at the University of South Florida College of Medicine and a Member-In-Residence in the Health Outcomes and Behavior Program at H. Lee Moffitt Cancer Center.
She currently holds an adjunct faculty appointment at the University of South Florida College of Public Health and is an Adjunct Scientist in the Clinical Genetics Branch at the National Cancer Institute.
research interests focus on awareness, knowledge, and use of genetic testing for inherited cancer susceptibility in the general population, minority groups, physicians and at-risk populations.
In order to further develop these interests, she
has successfully obtained peer-reviewed extramural funding from several national agencies.
In January 2006, Dr. Vadaparampil
was awarded a five-year American Cancer Society Mentored Research Scholar Grant to explore the impact of genetic counseling on recently diagnosed breast cancer patients.
The specific aims of the study are to examine: factors that predict whether a woman receives genetic counseling during or after she
definitive breast cancer treatment; patient satisfaction with BRCA1/2 genetic counseling; and the impact of BRCA1/2 genetic counseling in reducing decisional conflict about proceeding with BRCA1/2 genetic testing.
With the information obtained from the present study, Dr. Vadaparampil
will develop interventions designed to optimize the timing, content, and process of BRCA1/2 counseling and testing for breast cancer patients.
In addition, Dr. Vadaparampil
also obtained an R03 Grant from the National Human Genome Research Institute
The specific aims of this study are to apply Social Marketing theory to: examine knowledge, attitudes, and behaviors related to cancer genetics among Mexican, Puerto Rican, and Cuban women at increased risk for hereditary breast and ovarian cancer (HBOC); develop a series of culturally relevant messages related to HBOC and genetic counseling and testing specific to Mexican, Puerto Rican, and Cuban American women at increased risk for HBOC; and identify appropriate dissemination channels for these messages.
Study findings will serve as the basis for a larger intervention trial based in a public health department setting to educate Hispanic women at increased risk for HBOC about genetic counseling and testing for HBOC that will apply the final three phases of Social Marketing including: pretesting, implementation, and evaluation of the messages.
Dr. Vadaparampil also serves as a collaborator/co-investigator on several cancer prevention and control studies in the areas of physician knowledge and use of genetic testing for inherited cancer susceptibility, establishing the prevalence of BRCA1/2 mutations in the African American population, psychosocial aspects of familial testicular cancer, health care provider discussion of fertility preservation among pediatric and young adult cancer patients and their families, and the psychosocial impact of HPV on men.